43 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
shareholders and shareholders who do not have a personal interest in the proposal does not exceed two-percent (2%) of our outstanding voting rights.
Shareholders … outstanding voting rights.
We are unaware of any shareholder that would be deemed to be a controlling shareholder of the Company as of the date
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
of the shareholder) owns at least 5% of the outstanding shares or voting rights, serves as a director or chief executive officer or has the right to appoint one
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
be certificated or uncertificated, subject to the Companies Law.
Voting. The ordinary shares do not have cumulative voting rights in the election of directors … outstanding voting rights. A meeting adjourned for lack of a quorum is generally adjourned to the same day in the following week at the same time and place
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
and shareholders who do not have a personal interest in the proposal does not exceed two-percent (2%) of our outstanding voting rights.
Shareholders may review … does not exceed two-percent (2%) of our outstanding voting rights.
We are unaware of any shareholder that would be deemed to be a controlling
F-3
x99y3f
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.2
rwy0k1t7is9ui
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
9l21 xgqz9
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-10.1
4wb5aa eqcd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
t1yv7 0e1jg3
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
9ui88b6sxg
9 Feb 21
Prospectus supplement for primary offering
4:56pm
424B5
qkav4 8drapjr
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
xrtgx7ymbvnzigwizt6
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
jtj1idn93m3e0zdijy
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.2
oeef3ga8hoyx
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.1
zn8nx16xrk9 bywk
5 Mar 20
Report of Foreign Private Issuer
8:16am